TAZTIA
- Product NDC
- 62037-699
- 11-digit product format
- 620370699
- Labeler code
- 62037
- Product ID
- 62037-699_ef8c3181-0515-4824-98b4-7504dbab84e3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Diltiazem Hydrochloride
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Actavis Pharma, Inc.
- Application
- ANDA075401
- Marketing category
- ANDA
- Marketing start
- 2003-04-10
- Marketing end
- 0000-00-00
- Substance
- DILTIAZEM HYDROCHLORIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 62037-699-30 | 62037069930 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (62037-699-30) | 2003-04-10 | 0000-00-00 | No | No | Current |
| 62037-699-90 | 62037069990 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (62037-699-90) | 2003-04-10 | 0000-00-00 | No | No | Current |